Johnson Financial Group Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 16,734 shares of the healthcare product maker’s stock after selling 679 shares during the quarter. Johnson Financial […]